itraconazole has been researched along with Health Care Associated Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Matta, VL | 1 |
| de Souza Carvalho Melhem, M | 1 |
| Colombo, AL | 1 |
| Moretti, ML | 1 |
| Rodero, L | 1 |
| Duboc de Almeida, GM | 1 |
| dos Anjos Martins, M | 1 |
| Costa, SF | 1 |
| Souza Dias, MB | 1 |
| Nucci, M | 1 |
| Levin, AS | 1 |
| Zorzi, RR | 1 |
| Jorge, SD | 1 |
| Palace-Berl, F | 1 |
| Pasqualoto, KF | 1 |
| Bortolozzo, Lde S | 1 |
| de Castro Siqueira, AM | 1 |
| Tavares, LC | 1 |
2 other studies available for itraconazole and Health Care Associated Infection
| Article | Year |
|---|---|
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Mic | 2007 |
Exploring 5-nitrofuran derivatives against nosocomial pathogens: synthesis, antimicrobial activity and chemometric analysis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cross Infection; Dose-Response Relationship, Dru | 2014 |